Rock Springs Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
EC
BI
O
6CM
PM
SCM
SCM
Rock Springs Capital Management's LKFT Position: Q3 2021 in Review
Rock Springs Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 165,000 shares — an estimated $11.4M sold.
Rock Springs Capital Management first reported a position in LKFT in Q2 2015 and held it in 25 quarters. The position peaked at $36.2M in Q4 2019. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.
- Rock Springs Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
- Rock Springs Capital Management sold 165,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $11.4M.
- Rock Springs Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 25 quarters.
- Rock Springs Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $36.2M in Q4 2019.
- 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.
Based on Rock Springs Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.